The Food and Drug Administration (FDA)
is reminding consumers that some drugs to treat insomnia could make them less
able the next morning to perform activities for which they must be fully alert,
including driving a car. FDA has informed the manufacturers of products containing zolpidem that
the recommended dose for women for both immediate- and extended-release
products should be lowered. FDA is also suggesting a lower dose range
for men. To learn more: http://go.usa.gov/YjhH
|